These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26195525)

  • 1. Toxic Profile of Benznidazole in Patients with Chronic Chagas Disease: Risk Factors and Comparison of the Product from Two Different Manufacturers.
    Molina I; Salvador F; Sánchez-Montalvá A; Treviño B; Serre N; Sao Avilés A; Almirante B
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6125-31. PubMed ID: 26195525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of cytokine profile and HLA association in benznidazole related cutaneous reactions in patients with Chagas disease.
    Salvador F; Sánchez-Montalvá A; Martínez-Gallo M; Sala-Cunill A; Viñas L; García-Prat M; Aparicio G; Sao Avilés A; Artaza MÁ; Ferrer B; Molina I
    Clin Infect Dis; 2015 Dec; 61(11):1688-94. PubMed ID: 26265500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized trial of posaconazole and benznidazole for chronic Chagas' disease.
    Molina I; Gómez i Prat J; Salvador F; Treviño B; Sulleiro E; Serre N; Pou D; Roure S; Cabezos J; Valerio L; Blanco-Grau A; Sánchez-Montalvá A; Vidal X; Pahissa A
    N Engl J Med; 2014 May; 370(20):1899-908. PubMed ID: 24827034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nifurtimox therapy for Chagas disease does not cause hypersensitivity reactions in patients with such previous adverse reactions during benznidazole treatment.
    Pérez-Molina JA; Sojo-Dorado J; Norman F; Monge-Maillo B; Díaz-Menéndez M; Albajar-Viñas P; López-Vélez R
    Acta Trop; 2013 Aug; 127(2):101-4. PubMed ID: 23583863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicity of nifurtimox as second-line treatment after benznidazole intolerance in patients with chronic Chagas disease: when available options fail.
    Crespillo-Andújar C; Chamorro-Tojeiro S; Norman F; Monge-Maillo B; López-Vélez R; Pérez-Molina JA
    Clin Microbiol Infect; 2018 Dec; 24(12):1344.e1-1344.e4. PubMed ID: 29906591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Side effects of benznidazole treatment in a cohort of patients with Chagas disease in non-endemic country.
    Carrilero B; Murcia L; Martínez-Lage L; Segovia M
    Rev Esp Quimioter; 2011 Sep; 24(3):123-6. PubMed ID: 21947093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe immune thrombocytopaenia in a patient taking benznidazole for chronic Chagas disease.
    Crespillo-Andújar C; Calbacho Robles M; Norman FF; Pérez-Molina JA
    BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29588298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of benznidazole use in the treatment of chronic Chagas' disease.
    Hasslocher-Moreno AM; do Brasil PE; de Sousa AS; Xavier SS; Chambela MC; Sperandio da Silva GM
    J Antimicrob Chemother; 2012 May; 67(5):1261-6. PubMed ID: 22331592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arthritis and benznidazole: more closely related than we thought.
    Aldasoro E; Pinazo MJ; Oliveira I; Munoz J; Posada E; Requena-Méndez A; Serret N; Gascon J
    Antimicrob Agents Chemother; 2015 Jan; 59(1):727-9. PubMed ID: 25385100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerance of benznidazole in a United States Chagas Disease clinic.
    Miller DA; Hernandez S; Rodriguez De Armas L; Eells SJ; Traina MM; Miller LG; Meymandi SK
    Clin Infect Dis; 2015 Apr; 60(8):1237-40. PubMed ID: 25601454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adverse reactions in Chagas disease patients treated with benznidazole, in the State of Ceará].
    de Pontes VM; Souza Júnior AS; Cruz FM; Coelho HL; Dias AT; Coêlho IC; Oliveira Mde F
    Rev Soc Bras Med Trop; 2010; 43(2):182-7. PubMed ID: 20464150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benznidazole treatment safety: the Médecins Sans Frontières experience in a large cohort of Bolivian patients with Chagas' disease.
    Sperandio da Silva GM; Mediano MFF; Hasslocher-Moreno AM; Holanda MT; Silvestre de Sousa A; Sangenis LHC; Brasil PEAAD; Mejía RA; Fux CP; Cubides JC; Saraiva RM; Brum-Soares LM
    J Antimicrob Chemother; 2017 Sep; 72(9):2596-2601. PubMed ID: 28645201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities.
    Viotti R; Vigliano C; Lococo B; Alvarez MG; Petti M; Bertocchi G; Armenti A
    Expert Rev Anti Infect Ther; 2009 Mar; 7(2):157-63. PubMed ID: 19254164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interventional study in the natural evolution of Chagas disease. Evaluation of specific antiparasitic treatment. Retrospective-prospective study of antiparasitic therapy].
    Gallerano RR; Sosa RR
    Rev Fac Cien Med Univ Nac Cordoba; 2000; 57(2):135-62. PubMed ID: 12934232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seronegative conversion after incomplete benznidazole treatment in chronic Chagas disease.
    Alvarez MG; Vigliano C; Lococo B; Petti M; Bertocchi G; Viotti R
    Trans R Soc Trop Med Hyg; 2012 Oct; 106(10):636-8. PubMed ID: 22898619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse systemic reaction to benznidazole.
    Coronel MV; Frutos LO; Muñoz EC; Valle DK; Rojas DH
    Rev Soc Bras Med Trop; 2017; 50(1):145-147. PubMed ID: 28327820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety Profile of Benznidazole in the Treatment of Chronic Chagas Disease: Experience of a Referral Centre and Systematic Literature Review with Meta-Analysis.
    Crespillo-Andújar C; Venanzi-Rullo E; López-Vélez R; Monge-Maillo B; Norman F; López-Polín A; Pérez-Molina JA
    Drug Saf; 2018 Nov; 41(11):1035-1048. PubMed ID: 30006773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse events after the use of benznidazole in infants and children with Chagas disease.
    Altcheh J; Moscatelli G; Moroni S; Garcia-Bournissen F; Freilij H
    Pediatrics; 2011 Jan; 127(1):e212-8. PubMed ID: 21173000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What to expect and when: benznidazole toxicity in chronic Chagas' disease treatment.
    Aldasoro E; Posada E; Requena-Méndez A; Calvo-Cano A; Serret N; Casellas A; Sanz S; Soy D; Pinazo MJ; Gascon J
    J Antimicrob Chemother; 2018 Apr; 73(4):1060-1067. PubMed ID: 29351667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart rate variability in chronic Chagas patients before and after treatment with benznidazole.
    Oliveira LF; Silva VJ; Lages-Silva E; Molina RJ; Fuzissaki J; Niederhaur S; Prata A; Correia D
    Auton Neurosci; 2010 Dec; 158(1-2):118-22. PubMed ID: 20558113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.